Document is current
Any future updates will be listed below
-
Authors
Snetkova, Valentina
Galan, Carolina
Lopez, Romain
Rios, Antonio R.
Kudo, Takamasa https://orcid.org/0000-0002-9709-5549
Dorighi, Kristel https://orcid.org/0009-0002-7695-572X
Warming, Søren https://orcid.org/0000-0002-5721-0741
Haley, Benjamin J. https://orcid.org/0000-0002-0074-0020
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 20 May 2026
First Online: 2 June 2026
Competing interests
: Genentech has submitted a PCT patent application related to the Cas12a-based Perturb-seq work described here with V.S., C.G., K.D., S.W., and B.J.H. as inventors. V.S., C.G., K.D., S.W., and B.J.H. are equity holders in Roche. The remaining authors declare no competing interests.
